Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-22-000024
Filing Date
2022-10-11
Accepted
2022-10-11 17:07:47
Documents
1
Period of Report
2022-10-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5885
  Complete submission text file 0000711377-22-000024.txt   7213
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O NEOGEN CORPORATION 620 LESHER PLACE LANSING MI 48912
Business Address
Gupta Aashima (Reporting) CIK: 0001946262 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 221304711